IP Library Granted Patent US 10,633,626
Granted Patent B2
US 10,633,626 · App. 16/597,826 · Granted Apr 28, 2020

Instruments, modules, and methods for improved detection of edited sequences in live cells

Inventors: Andrew Garst (Boulder, CO); Richard Fox (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Don Masquelier (Boulder, CO)
Assignee: Inscripta, Inc.
C12M47/04C12M23/44C12M29/04C12M33/00C12M47/02C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,626
App. No.
16/597,826
Granted
Apr 28, 2020
Kind
B2
Abstract

The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.

Claims (39)

1. A method for enriching edited cells during nucleic acid-guided nuclease editing comprising:

transforming cells with one or more vectors comprising a promoter driving expression of a CRISPR nuclease, an inducible promoter driving transcription of a guide nucleic acid covalently-linked to a DNA donor sequence and wherein each of the one or more vectors comprises a gene for a selectable marker;

diluting the transformed cells to a cell concentration to substantially singulate the transformed cells on a first substrate;

growing the cells to form colonies on the first substrate under conditions that allow genome repair;

initiating editing in the cells growing on the first substrate by inducing the inducible promoter driving transcription of the guide nucleic acid to produce induced cells;

growing the induced cells into terminal-sized colonies;

making a replica of the first substrate forming a second substrate;

growing and inducing cells on the second substrate under conditions that do not allow genome repair;

comparing cell growth on the first and second substrates; and

selecting cells from the first substrate that grow on the first substrate but do not grow on the second substrate.

2. The method of claim 1 , wherein the promoter driving transcription the guide nucleic acid and donor DNA is a pL promoter.

3. The method of claim 1 , wherein the promoter driving expression of the CRISPR nuclease is an inducible promoter.

4. The method of claim 3 , wherein the inducible promoter driving expression of each of the guide nucleic acid and the CRISPR nuclease is the same inducible promoter.

5. The method of claim 4 , wherein the inducible promoter driving expression of the guide nucleic acid and driving transcription of the guide nucleic acid is a pL promoter.

6. The method of claim 1 , wherein the DNA donor sequence further comprises a PAM-altering sequence.

7. The method of claim 1 , further comprising adding selective agents to medium of the first substrate to select for the one or more vectors.

8. The method of claim 1 , wherein the guide nucleic acid is a guide RNA.

9. The method of claim 1 , wherein the cells grown on the first and second substrates are bacteria cells and the engine vector further comprises a recombineering system.

10. The method of claim 1 , wherein all of the coding sequence for the CRISPR nuclease, guide nucleic acid and donor DNA are all on the same vector.

11. A method for enriching edited cells during nucleic acid-guided CRISPR nuclease editing comprising:

transforming cells with one or more vectors comprising a promoter driving expression of a CRISPR nuclease, an inducible promoter driving transcription of a guide nucleic acid covalently-linked to a DNA donor sequence and wherein each of the one or more vectors comprises a gene for a selectable marker;

diluting the transformed cells to a cell concentration to substantially singulate the transformed cells on a first substrate;

growing the cells to form colonies on the first substrate under conditions that allow genome repair;

initiating editing in the cells growing on the first substrate by inducing the inducible promoter driving transcription of the guide nucleic acid to produce induced cells;

selecting cells from the substantially singulated induced cells from the first substrate and arraying the selected cells on a second substrate;

making a replica of the second substrate forming a third substrate;

growing and inducing cells on the second substrate under conditions that allow genome repair;

growing and inducing cells on the third substrate under conditions that do not allow genome repair;

comparing cell growth on the second and third substrates; and

selecting cells from the second substrate that grow on the second substrate but do not grow on the third substrate.

12. The method of claim 11 , wherein the promoter driving transcription the guide nucleic acid and donor DNA is a pL promoter.

13. The method of claim 11 , wherein the promoter driving expression of the CRISPR nuclease is an inducible promoter.

14. The method of claim 13 , wherein the inducible promoter driving expression of each of the guide nucleic acid and the CRISPR nuclease is the same inducible promoter.

15. The method of claim 14 , wherein the inducible promoter driving expression of the guide nucleic acid and driving transcription of the guide nucleic acid is a pL promoter.

16. The method of claim 11 , wherein the DNA donor sequence further comprises a PAM-altering sequence.

17. The method of claim 11 , further comprising adding selective agents to medium of the first substrate to select for the one or more vectors.

18. The method of claim 11 , wherein the cells grown on the first, second and third substrates are yeast cells.

19. The method of claim 11 , wherein the cells grown on the first, second and third substrates are bacteria cells and the engine vector further comprises a recombineering system.

20. The method of claim 11 , wherein the cells grown on the first, second and third substrates are mammalian cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: GARST, ANDREW; FOX, RICHARD; BELGRADER, PHILLIP; MASQUELIER, DON
To: INSCRIPTA, INC.
Reel/Frame 050672/0164 →
Continuity (7)
Continuation 16454865 · Jun 27, 2019
Continuation 16399988 · Apr 30, 2019
Provisional Application 62718449 · Aug 14, 2018
Provisional Application 62735365 · Sep 24, 2018
Provisional Application 62781112 · Dec 18, 2018
Provisional Application 62779119 · Dec 13, 2018
Related Publication 20200063088A1 · Feb 27, 2020
Cited By (1)
US 12,201,699